港股異動 | 九興控股(1836.HK)大跌超10% 遭花旗降級至“沽售” 疫情或令銷售中斷
格隆匯6月29日丨九興控股(1836.HK)大跌10.28%,報8.73港元,暫成交1427萬港元,最新總市值69.4億港元。去年北美及歐洲仍然為集團兩個最大市場,分別佔集團總收入的51.2%及27.6%。歐美疫情嚴峻,美國昨日新增4.26萬例,連續三天單日新增超4萬例。花旗指出,公共衞生事件令公司銷售中斷,消費者需求疲弱。預計該集團今年第二季度出貨量數據表現疲弱,因此將對其展開30天負面催化劑觀察。下調目標價42.4%,由13.2港元調低至7.6港元,評級由“買入”降至“沽售”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.